A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 1000
- Registration Number
- NCT06733402
- Locations
- 🇺🇸
Taro Pharmaceuticals USA Inc., Hawthorne, New York, United States
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 382
- Registration Number
- NCT06673641
- Locations
- 🇺🇸
Taro Pharmaceuticals USA Inc., Hawthorne, New York, United States
A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 476
- Registration Number
- NCT06673654
- Locations
- 🇺🇸
Taro Pharmaceuticals USA Inc., Hawthorne, New York, United States
A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 430
- Registration Number
- NCT06305637
- Locations
- 🇺🇸
Taro, Hawthorne, New York, United States
A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 762
- Registration Number
- NCT06063473
- Locations
- 🇺🇸
Taro Pharmaceuticals USA Inc., Hawthorne, New York, United States
A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 402
- Registration Number
- NCT05282771
- Locations
- 🇺🇸
Catawba Research, LLC, Charlotte, North Carolina, United States
A Study Comparing Oxymetazoline 1% Cream to RHOFADE
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 82
- Registration Number
- NCT05148689
- Locations
- 🇺🇸
WAYcro, Dallas, Texas, United States
A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 973
- Registration Number
- NCT04883736
- Locations
- 🇺🇸
Catawba Research, LLC, Charlotte, North Carolina, United States
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 160
- Registration Number
- NCT04883593
- Locations
- 🇺🇸
Catawba Research, LLC, Charlotte, North Carolina, United States
A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 978
- Registration Number
- NCT04797793
- Locations
- 🇺🇸
Catawba Research, LLC, Charlotte, North Carolina, United States
© Copyright 2024. All Rights Reserved by MedPath